BRIEF

on BASTIDE (EPA:BLC)

Annual results 2023-2024: Solid performance of Bastide with prudent financial management

Stock price chart of BASTIDE (EPA:BLC) showing fluctuations.

Groupe Bastide, a major player in home healthcare services in Europe, has presented its annual results for the 2023-2024 financial year. Revenue reached €529.8 million, marking organic growth of 7.4%, largely driven by its specialist respiratory and diabetes services, which account for 62% of its business.

The current operating margin stood at 8.5%, slightly exceeding forecasts. However, net income fell to EUR 1.2 million, impacted by losses of EUR 8.3 million on activities currently being sold in Switzerland.

Financially, Bastide has maintained strict discipline. Despite a negative financial result of €22.4 million, cash management has proven effective, with a positive operating free cash flow of €20.8 million. Deleveraging is also a key objective for 2024-2025, with targeted asset disposal projects to strengthen the financial position.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all BASTIDE news